PharmaShots | Incisive News in 3 Shots

Subscribe Now

KEYNOTE-604

Merck & Co Reports Results of Keytruda in P-III KEYNOTE-604 Trial in 1L Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Merck & Co Reports Results of Keytruda in P-III KEYNOTE-604 Trial in 1L Patients with Extensive Stage Small Cell Lung Cancer (...

January 7, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us